Approval · Notice of Compliance 757 · 2002
PEGETRON: Notice of Compliance 757
Issued May 31, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 757
- Date
- May 31, 2002
- Company
- Schering Canada Inc.
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Biological response modifier plus antiviral agent
Products in this notice
Medicinal ingredients
- RIBAVIRIN 200 MG per CAP
- PEGINTERFERON ALFA-2B 50 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 80 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 100 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 120 MCG per 0.5ML
- PEGINTERFERON ALFA-2B 150 MCG per 0.5ML